Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the ona domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/risezcom/public_html/cord-blood.org.uk/wp-includes/functions.php on line 6170
New Treatment Advancement in Cancer using Umbilical Cord Blood Cells - Cord Blood

Cord Blood

and Stem Cell Banking

New Treatment Advancement in Cancer using Umbilical Cord Blood Cells

Image of blood cells

Researchers from Singapore General Hospital (SGH) have made a breakthrough in cancer treatment involving white blood cells from umbilical cord blood. These cells, called gamma delta T-cells (GDT), have been found to be highly effective against cancer cells.

GDT-cells are a type of white blood cell that fight off diseases and infections in the body. They are especially good at detecting and attacking cancer cells. While these cells can also be found in adults, studies have shown that a specific type of GDT-cell found in umbilical cord blood is more powerful against cancer.

Previous attempts to use GDT-cells as a cancer treatment in adults have not been very successful. The response rates were low and the treatment didn’t work well. That’s why the researchers decided to focus on umbilical cord blood instead.

By using samples from the Singapore Cord Blood Bank, the team developed a way to increase the number of GDT-cells in the samples. They believe that these GDT-cells from umbilical cord blood may have a longer lifespan, which can help prevent cancer from coming back.

Currently, these umbilical cord blood cells are not being used to their full potential because there is a concern that there may not be enough of them for treatment. However, this study has shown that it is possible to multiply these cells and use them effectively in cancer treatment.

The researchers will continue their work and plan to start clinical trials in 2024 to test the effectiveness of these umbilical cord blood cells in treating leukemia and lymphoma.

This breakthrough in cancer treatment gives hope for a more effective and targeted approach to fighting cancer. It is an exciting development that could potentially save many lives in the future.